WHO ICTRP trial
HIPEC/FLOT9 - PREVENT
CTIS2024-517300-10-01 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-517300-10-01 |
|---|---|
| Public title | HIPEC/FLOT9 - PREVENT |
| Scientific title | Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction Type II/III adenocarcinoma – The phase III “PREVENT” trial of the AIO /CAOGI /ACO - HIPEC/FLOT9 |
| Primary sponsor | Krankenhaus Nordwest GmbH |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | Germany |
| Conditions | Resectable diffuse type gastric and gastroesophageal junction Typ II/III adenocarcinoma;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Interventions | Product Name: CISPLATIN, Product Code:SUB07483MIG, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: OXALIPLATIN, Product Code:SUB09490MIG, Pharmaceutical Form: CONCENTRATE FOR SOLUTION FOR… |
| Registration date | Nov 10, 2024 |
| Target size | 200 |
| Secondary IDs | NCT04447352;2017-003832-35 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: